|
|
Commentary |
Commentary: Calcium antagonist controversy, does the accusing finger also point to beta-blockers and methyldopa? |
201 |
LH Opie
|
Full Article (PDF)
|
|
Original Articles |
Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP) |
205 |
CJ Bulpitt,
AJ Palmer,
DG Beevers,
EC Coles,
JGG Ledingham,
JC Petrie & J Webster
|
Abstract
Full Article (PDF)
|
|
Hypertension awareness, treatment and control in the community: is the rule of halves still valid? |
213 |
P Marques-Vidal & J Tuomilehto
|
Abstract
Full Article (PDF)
|
|
Patients perceptions of changes in their blood pressure |
221 |
P Cantillon,
M Morgan,
R Dundas,
J Simpson,
J Bartholomew & A Shaw
|
Abstract
Full Article (PDF)
|
|
Variation of ambulatory blood pressure in healthy middle-aged men |
227 |
A Loimaala,
V Turjanmaa,
I Vuori,
P Oja,
M Pasanen & A Uusitalo
|
Abstract
Full Article (PDF)
|
|
Genetic and environmental factors regulating blood pressure in childhood: prospective study from 0 to 3 years |
233 |
A Guerra,
C Monteiro,
L Breitenfeld,
H Jardim,
C Rego,
D Silva,
A Prata,
J Matos,
A Pereira,
N Teixeira Santos & M Bicho
|
Abstract
Full Article (PDF)
|
|
Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension |
239 |
R Fiddes,
J Blumenthal,
JE Dawson,
E Dyckman,
PG St John Hammond,
S Harris,
KC Lasseter,
BS Levine,
R Montoro,
AL Niederman,
PH Ratner,
S Rosenblatt,
PD Toth,
J Vergis & J Codispoti
|
Abstract
Full Article (PDF)
|
|
Special Article |
World Hypertension League Statement. Hypertension Control in the World: an agenda for the coming decade. Based on the 1995 WHL Ottawa Declaration |
245 |
DG Beevers
|
Full Article (PDF)
|
|